Placebo Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma
Phase of Trial: Phase II
Latest Information Update: 18 May 2018
At a glance
- Drugs ANB 020 (Primary)
- Indications Asthma
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Sponsors AnaptysBio
- 26 Mar 2018 According to an AnaptysBio media release, top-line data are anticipated in the third quarter of 2018.
- 07 Nov 2017 According to an AnaptysBio media release, top-line data from this trial are expected in the second quarter of 2018.
- 10 Oct 2017 Status changed from planning to recruiting according to an AnaptysBio media release.